Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd

Next 500 2024
+ 4 More
+ 4 More
OVERVIEW
FINANCIALS

About

Caplin Point Laboratories is a pharmaceutical company established in 1990 to provide external applications like ointments, creams, and more. With the help of 4 manufacturing sites in India and 3 R&D facilities, Caplin produces over 4000 products with more than 650 formulations in 36 different therapeutic areas. For products where in-house manufacturing is restricted, Caplin is part of an Outsourced Manufacturing initiative wherein it develops and transfers product technology to other approved sites. It is increasingly supplying its licensed active pharmaceutical ingredients (APIs), finished formulations, and generics, as well as clinical research, to Latin America, Africa, the USA, and the EU.

Incorporation Year: 1990
Headquarters: Chennai
Top Management: C.C.Paarthipan
Industry: Pharma

Featured In Fortune India Ranking

Next 500 India
#363(2024)#285(2023)#270(2022)#213(2021)#485(2020)
#363(2024)#285(2023)#270(2022)#213(2021)#485(2020)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
1,836
(INR Cr)
Net Operating Income
1,694
(INR Cr)
Assets
2,368
(INR Cr)
Profit
457
(INR Cr)
Net Worth
2,099
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS20242023202220212020201920182017201620152014201320122011201020092008
Revenue
(INR Cr)
1836
17.0%
1570
17.1%
1340
33.7%
1002
-8.8%
1100
62.2%
678
22.2%
555
34.9%
411
69.3%
243
-4.9%
256
43.8%
178
36.4%
130
19.0%
110
30.7%
84
37.0%
61
-4.7%
64
-0.1%
64
-
Net Operating Income
(INR Cr)
1694
15.50%
1467
15.54%
1269
19.61%
1061
22.95%
863
33.07%
649
20.16%
540
34.41%
402
68.25%
239
-5.18%
252
45.46%
173
36.26%
127
18.49%
107
32.72%
81
0.00%
58
-1.81%
59
-5.06%
62
63.91%
Profit
(INR Cr)
457
21.5%
376
25.5%
300
23.8%
242
12.7%
215
21.8%
177
22.0%
145
51.4%
96
108.9%
46
11.5%
41
58.8%
26
84.9%
14
74.5%
8
27.6%
6
88.6%
3
50.0%
2
113.5%
1
-
Assets
(INR Cr)
2368
22.8%
1928
26.0%
1530
23.6%
1237
22.7%
1009
57.8%
639
72.8%
370
63.4%
226
71.4%
132
37.0%
96
45.9%
66
36.8%
48
18.4%
41
4.4%
39
9.1%
36
10.4%
32
-0.5%
33
-
Net Worth
(INR Cr)
2099
26.2%
1664
31.3%
1267
30.8%
969
11.0%
873
46.3%
597
64.1%
364
61.9%
225
80.7%
124
39.1%
89
44.9%
62
56.7%
39
32.1%
30
17.7%
25
0.0%
22
7.9%
20
12.4%
18
28.0%
Employee Cost
(INR Cr)
144
4.8%
137
18.8%
115
12.5%
103
51.3%
68
43.8%
47
20.4%
39
27.0%
31
66.8%
18
-1.7%
19
47.2%
13
63.4%
8
23.0%
6
53.4%
4
56.8%
3
-1.5%
3
-21.6%
3
-
Interest Cost
(INR Cr)
11120111011111111
Cash & Bank Balance
(INR Cr)
5534934634382231537993684527173222151710
Total Debt
(INR Cr)
2521839111223571010911

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS20242023202220212020201920182017201620152014201320122011201020092008
Profit As % Of Revenues 24.9%24.0%22.4%24.2%19.6%26.1%26.1%23.2%18.8%16.1%14.5%10.7%7.3%7.5%5.4%3.5%1.6%
Profit As % Of Assets 19.3%19.5%19.6%19.6%21.3%27.6%39.2%42.3%34.7%42.6%39.1%28.9%19.6%16.1%9.3%6.9%3.2%
Profit As % Of Networth 21.8%22.6%23.7%25.0%24.6%29.6%39.8%42.5%36.8%45.9%41.9%35.5%26.8%24.8%15.3%11.0%5.8%
Interest Cost to EBITDA % 0.1%0.2%0.2%0.5%0.1%0.3%0.3%0.4%0.5%1.6%1.9%3.5%11.3%13.0%43.6%45.9%39.0%
Debt to Equity Ratio 0.000.000.000.020.040.000.000.000.020.020.050.120.230.380.480.430.61
RONW 24.5%25.7%27.6%27.3%29.3%36.8%49.2%54.7%57.1%54.4%51.3%40.5%29.1%21.5%15.9%11.7%5.2%
ROCE 26.7%26.6%28.4%28.4%32.9%45.1%63.5%68.6%73.1%68.7%65.9%56.2%34.4%23.5%15.3%15.2%8.1%